<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "journalpublishing.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="2.0" xml:lang="en" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Med Internet Res</journal-id><journal-id journal-id-type="publisher-id">jmir</journal-id><journal-id journal-id-type="index">1</journal-id><journal-title>Journal of Medical Internet Research</journal-title><abbrev-journal-title>J Med Internet Res</abbrev-journal-title><issn pub-type="epub">1438-8871</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">v28i1e89240</article-id><article-id pub-id-type="doi">10.2196/89240</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Feasibility and Methodological Reflections From the Co-Creation of a Randomized Controlled Trial (The Kid&#x2019;s Trial): Decentralized, Child-Led Citizen-Science Study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Lepage</surname><given-names>Simone</given-names></name><degrees>MSci, BSc, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Flight</surname><given-names>Laura</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Totton</surname><given-names>Nikki</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Devane</surname><given-names>Declan</given-names></name><degrees>PhD, MSc</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref></contrib></contrib-group><aff id="aff1"><institution>School of Nursing, Midwifery &#x0026; Evidence Science, University of Galway</institution><addr-line>&#x00C1;ras Moyola, Upper Newcastle Rd</addr-line><addr-line>Galway</addr-line><country>Ireland</country></aff><aff id="aff2"><institution>HRB-Trials Methodology Research Network, University of Galway</institution><addr-line>Galway</addr-line><country>Ireland</country></aff><aff id="aff3"><institution>National Institute for Health and Care Excellence</institution><addr-line>Manchester</addr-line><addr-line>England</addr-line><country>United Kingdom</country></aff><aff id="aff4"><institution>Sheffield Centre for Health and Related Research (SCHARR), School of Medicine and Population Health, University of Sheffield</institution><addr-line>Sheffield</addr-line><addr-line>England</addr-line><country>United Kingdom</country></aff><aff id="aff5"><institution>Evidence Synthesis Ireland, University of Galway</institution><addr-line>Galway</addr-line><country>Ireland</country></aff><aff id="aff6"><institution>Cochrane Ireland, University of Galway</institution><addr-line>Galway</addr-line><country>Ireland</country></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Balcarras</surname><given-names>Matthew</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name name-style="western"><surname>Pagnamenta</surname><given-names>Emma</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Liu</surname><given-names>Zhao</given-names></name></contrib></contrib-group><author-notes><corresp>Correspondence to Simone Lepage, MSci, BSc, PhD, School of Nursing, Midwifery &#x0026; Evidence Science, University of Galway, &#x00C1;ras Moyola, Upper Newcastle Rd, Galway, Ireland, +353 (0)91 493432; <email>simone.lepage@universityofgalway.ie</email></corresp></author-notes><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>28</day><month>8</month><year>2026</year></pub-date><volume>28</volume><elocation-id>e89240</elocation-id><history><date date-type="received"><day>09</day><month>12</month><year>2025</year></date><date date-type="rev-recd"><day>14</day><month>05</month><year>2026</year></date><date date-type="accepted"><day>01</day><month>06</month><year>2026</year></date></history><copyright-statement>&#x00A9; Simone Lepage, Laura Flight, Nikki Totton, Declan Devane. Originally published in the Journal of Medical Internet Research (<ext-link ext-link-type="uri" xlink:href="https://www.jmir.org">https://www.jmir.org</ext-link>), 28.8.2026. </copyright-statement><copyright-year>2026</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research (ISSN 1438-8871), is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="https://www.jmir.org/">https://www.jmir.org/</ext-link>, as well as this copyright and license information must be included.</p></license><self-uri xlink:type="simple" xlink:href="https://www.jmir.org/2026/1/e89240"/><abstract><sec><title>Background</title><p>Limited public understanding of randomized controlled trials (RCTs) hinders recruitment, retention, and confidence in research. Early exposure to trial concepts may strengthen health literacy and research engagement. The Kid&#x2019;s Trial was a global, decentralized, child-led study that cocreated and conducted an RCT to help children understand trials and their importance and to improve critical thinking.</p></sec><sec><title>Objective</title><p>This paper evaluated the feasibility and methodological implications of engaging children in the cocreation and conduct of a fully online RCT.</p></sec><sec sec-type="methods"><title>Methods</title><p>The Kid&#x2019;s Trial ed a dedicated website guiding children through each step of designing and conducting an RCT. Materials were codeveloped with 2 patient and public involvement groups of children and parents. Any child aged 7-12 years could take part in as many steps as desired. Recruitment combined online and offline strategies, and engagement and self-reported learning were descriptively analyzed. The cocreated Randomized Evaluation of Sleeping With a Toy or Comfort Item (REST) trial was a 2-arm, pragmatic RCT comparing one week of sleeping with a comfort item versus without a comfort item. The primary outcome was sleep-related impairment, and the secondary outcome was overall sleep quality. Analyses followed an intention-to-treat (ITT) approach using mixed effects models adjusted for baseline measures.</p></sec><sec sec-type="results"><title>Results</title><p>Overall, 224 children participated in at least one step of The Kid&#x2019;s Trial. Participation varied: 37% (n=82) completed one step, and 21% (n=48) completed 6 surveys. The REST trial randomized 139 children, with 73% (n=101) completing outcome surveys. Adjusted mean differences (intervention &#x2013; control) were &#x2212;0.53 (95% CI &#x2212;3.40 to 2.34) for sleep-related impairment (<italic>P</italic>=.71) and 0.28 (95% CI 0.01-0.55) for sleep quality (<italic>P</italic>=.04). The difference was small and was not supported by sensitivity analyses. Poststudy responses (n=20) suggested improved self-reported trial understanding among respondents but were limited by low response rate and potential selection bias.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>The Kid&#x2019;s Trial demonstrates the feasibility of a decentralized, child-led RCT cocreated through participatory citizen-science methods. Children can meaningfully contribute to trial design and conduct, and experiential participation may support engagement with trial concepts. Future studies should enhance engagement through community partnerships, shorter intervals between steps, and embedded learning assessments to improve inclusivity and retention.</p></sec><sec><title>Trial Registration</title><p>ISRCTN Registry ISRCTN13756306; https://www.isrctn.com/ISRCTN13756306</p></sec></abstract><kwd-group><kwd>randomized controlled trial</kwd><kwd>children</kwd><kwd>health literacy</kwd><kwd>citizen science</kwd><kwd>decentralized trial</kwd><kwd>public involvement</kwd><kwd>patient and public involvement</kwd></kwd-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Randomized controlled trials (RCTs) are widely regarded as the gold standard for evaluating the effectiveness of health care interventions. By minimizing bias, they can generate reliable evidence to guide clinical and policy decisions [<xref ref-type="bibr" rid="ref1">1</xref>]. Despite their importance, RCTs face persistent challenges, including difficulties in recruiting and retaining participants, complex logistics, and high operational costs [<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref>]. A limited public understanding of trials contributes to these challenges [<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref5">5</xref>].</p><p>Evidence suggests that when members of the public understand the purpose and processes of RCTs, they are more likely to support and participate in them [<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref6">6</xref>]. This has prompted researchers to explore ways to educate and engage the public in research. For example, in 2010, a Scottish collaboration launched a media campaign on television, radio, and newspapers featuring clinical researchers, general practitioners, and patients discussing the importance of RCTs [<xref ref-type="bibr" rid="ref7">7</xref>]. The organization &#x201C;Clinical Trials for All,&#x201D; established in 2023, is a noncommercial initiative aiming to &#x201C;increase global clinical trial awareness and participation by educating patients and caregivers about the opportunities and advantages of clinical research as a care option&#x201D; [<xref ref-type="bibr" rid="ref8">8</xref>].</p><p>While these initiatives are valuable, approaches that involve the public directly in the research process may offer a more experiential way to build understanding of how RCTs are designed, conducted, and used. The People&#x2019;s Trial, launched in 2019, involved over 3000 adults from 72 countries in the design and conduct of an online RCT led by the public [<xref ref-type="bibr" rid="ref9">9</xref>]. By making the research process participatory and transparent, the initiative successfully heightened public awareness and interest in clinical trials [<xref ref-type="bibr" rid="ref9">9</xref>]. However, there is limited evidence on how this participatory model can be applied with children, particularly in fully online settings.</p><p>The Kid&#x2019;s Trial was developed to address this gap by extending the participatory model used by The People&#x2019;s Trial to children aged 7-12 years. The Kid&#x2019;s Trial was conducted entirely online, and children were invited to take part in all aspects of a randomized trial, from generating questions and designing the study to participating in the trial they designed and deciding how to share the results. The Kid&#x2019;s Trial aimed to help children learn what RCTs are and why they matter by actively involving them in creating and running one, while encouraging them to think critically about the health information they encounter.</p><p>Focusing on children during middle childhood is relevant in this context because this developmental stage is marked by growing reasoning abilities, curiosity, and an openness to new ideas [<xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref11">11</xref>]. It is also a critical period for laying the foundations of health literacy, that is, the ability to access, understand, and appraise health information to make informed decisions [<xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref13">13</xref>]. In today&#x2019;s digital information landscape, where children are frequently exposed to numerous health claims, early exposure to evidence-based thinking is especially valuable [<xref ref-type="bibr" rid="ref14">14</xref>].</p><p>The Kid&#x2019;s Trial adopted a decentralized design, with all its trial activities conducted remotely using digital platforms. Decentralization includes strategies such as data collection via mobile devices or remote participation [<xref ref-type="bibr" rid="ref15">15</xref>], which can lessen participant burden, enhance access and inclusivity, and improve the efficiency of clinical research [<xref ref-type="bibr" rid="ref16">16</xref>-<xref ref-type="bibr" rid="ref18">18</xref>]. We incorporated active public and patient involvement (PPI) by creating 2 online advisory groups of children and parents to shape the study&#x2019;s direction and increase its relevance.</p><p>To reflect the structure of a clinical trial, The Kid&#x2019;s Trial was divided into a series of participatory steps that guided children through the research process, from choosing the question to sharing the results, as shown in <xref ref-type="fig" rid="figure1">Figure 1</xref>. Children contributed to each step of the process, including selecting the research question, defining trial procedures, taking part in the trial and reporting their results, and deciding how the findings would be shared.</p><fig position="float" id="figure1"><label>Figure 1.</label><caption><p>Steps of The Kid&#x2019;s Trial.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="jmir_v28i1e89240_fig01.png"/></fig><p>This study reports on The Kid&#x2019;s Trial as a global, decentralized, child-led citizen science study. We use the term citizen science to describe the participatory, child-led approach we used. The primary objective of The Kid&#x2019;s Trial was to evaluate the feasibility and methodological implications of engaging children in the cocreation and conduct of a fully online RCT. The study included an embedded proof-of-concept RCT, the Randomized Evaluation of Sleeping With a Toy or Comfort Item (REST) trial, which is presented here to illustrate the implementation of this approach. In doing so, this work demonstrates how children can meaningfully engage with core trial processes and considers whether this participation may support children&#x2019;s self-reported understanding of how trials are designed, conducted, and interpreted.</p></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2-1"><title>Ethical Considerations</title><p>The University of Galway Research Ethics Committee granted ethical approval for this study on January 16, 2023 (Ref: 2023.02.014).</p><sec id="s2-1-1"><title>Study Setting and Design</title><p>Children taking part in The Kid&#x2019;s Trial could join from anywhere, with all trial materials and information available on the website [<xref ref-type="bibr" rid="ref19">19</xref>]. To take part in any step of the study, children needed internet access via a computer, tablet, or mobile phone. Participation was intentionally flexible to align with the participatory citizen-science nature of the initiative, allowing children to join as many or as few steps as they wished. The Kid&#x2019;s Trial ran for 19 months, from March 11, 2024, to October 9, 2025.</p></sec></sec><sec id="s2-2"><title>PPI Groups</title><p>In this paper, we use the term PPI to refer specifically to the advisory groups that informed the study&#x2019;s design and conduct. Eight months before launching The Kid&#x2019;s Trial, we established a Children&#x2019;s Research Advisory Group (CRAG) and a Parents&#x2019; Research Advisory Group (PRAG), comprising 7 family units (8 children aged 7-11 years and 7 parents). Child literacy levels and parent education levels were not collected for PPI group members. These groups were recruited using social media and email campaigns. Parent-child dyads were recruited to support participation in a fully online setting, particularly for younger children. Meetings were held online to accommodate the geographic diversity of participating families (Estonia, Ireland, Kenya, Norway, Tanzania, and the United States).</p><p>Over approximately 18 months, members of the CRAG and PRAG collaborated with the research team to refine the visual identity and tone of The Kid&#x2019;s Trial website, codevelop age-appropriate consent and assent materials, shape the content and language of the animated explainer videos, and review survey wording for clarity and accessibility. Engagement was maintained through regular online meetings, structured feedback surveys, and anonymous polls. A detailed account of the activities, challenges, facilitators, and experiences of both PPI group members and researchers is provided in a separate report [<xref ref-type="bibr" rid="ref20">20</xref>].</p></sec><sec id="s2-3"><title>Website and Survey Development</title><sec id="s2-3-1"><title>Overview</title><p>The website served as the central hub for the study. It provided study information, introduced the research team, explained the involvement of the PPI groups, outlined data and privacy policies, and presented each step. Each step&#x2019;s webpage described its purpose, featured an animated explainer video, and linked participants to the corresponding survey. Surveys were accessed via a button that redirected to QuestionPro (QuestionPro Inc) survey software [<xref ref-type="bibr" rid="ref21">21</xref>]. The steps were opened sequentially, with survey links closing once each step was completed. The website&#x2019;s visual identity, including the logo and icons created by CRAG members, color scheme, fonts, and language, was co-designed with our PPI groups.</p></sec><sec id="s2-3-2"><title>Animated Videos</title><p>To help maintain engagement and accessibility, we created animated explainer videos for children and their parents using Powtoon (Powtoon.com, Inc) software [<xref ref-type="bibr" rid="ref22">22</xref>]. The research team drafted transcripts, developed animations, and shared drafts with the PPI groups for review. PPI feedback focused on both the animations and the language, and the groups requested an additional video explaining the concept of randomization. Children from the CRAG and our wider network narrated the videos. Ten videos were produced, introducing core concepts of RCTs and explaining the purpose of each step of The Kid&#x2019;s Trial, what participation involved, and how to take part. These animated videos were uploaded to the website and the study&#x2019;s YouTube (Google LLC) channel [<xref ref-type="bibr" rid="ref23">23</xref>].</p></sec><sec id="s2-3-3"><title>Recruitment</title><p>Recruitment was conducted using a combination of online and offline strategies, primarily aimed at parents. Online recruitment included social media posts on X (X Corp), Facebook (Meta Platforms, Inc), Instagram (Meta Platforms, Inc), TikTok (TikTok Ltd), Mastodon (Mastodon gGmbH), and LinkedIn (LinkedIn Corporation); email campaigns; listings on 2 websites that connect the public with research opportunities: the European Citizen Science (ECS) platform [<xref ref-type="bibr" rid="ref24">24</xref>] and Children Helping Science (CHS) [<xref ref-type="bibr" rid="ref25">25</xref>]; and promotion through newsletters and blogs within European and American research and trial communities. Offline recruitment included radio interviews; distributing flyers in schools, markets, and play centers; and collaborating with children&#x2019;s advocacy groups in countries where we lacked established networks. Recruitment efforts also sought to reach groups that are often underrepresented in research participation, including children from underserved communities, home-schooling networks, and Traveller community links.</p><p>Between March 11, 2024, and September 15, 2025, over 400 social media posts (both static and animated) were shared, approximately 1500 flyers were distributed, 2 national radio interviews were aired in Ireland, and more than 300 personal and professional contacts were emailed. During the third step, &#x201C;Running the trial!&#x201D; which had a target sample size (n=292), we expanded recruitment efforts by testing paid Google ads and running a 3-month paid Facebook campaign.</p><p>Recruitment was passive, requiring children and their caregivers to initiate contact with the trial via email, social media, or the website. The participant information leaflets (&#x201C;Parents&#x2019; Informational Flipbook&#x201D; and &#x201C;Children&#x2019;s Information Flipbook&#x201D;) were available on the website. Participants were informed, both in the flipbooks and during the consent and assent processes, that they could withdraw from the study at any time without consequences and that their data could be deleted prior to data analysis.</p></sec><sec id="s2-3-4"><title>Participants</title><p>Eligible participants were children aged 7-12 years who met the inclusion criteria, as confirmed through guardian consent and participant assent using QuestionPro [<xref ref-type="bibr" rid="ref21">21</xref>], as approved by our research ethics committee. The Kid&#x2019;s Trial was open globally, with no geographic exclusions. However, due to budget constraints, trial materials were only available in English. Because of the study&#x2019;s decentralized nature, children without internet access were inherently excluded. The inclusion and exclusion criteria were as follows:</p><sec id="s2-3-4-1"><title>Inclusion Criteria</title><p>Eligible children had to meet the following inclusion criteria:</p><list list-type="order"><list-item><p>Children aged 7-12 years</p></list-item><list-item><p>Sufficient proficiency in English to understand trial materials</p></list-item><list-item><p>Access to the trial&#x2019;s online platform</p></list-item><list-item><p>Guardian consent for participation</p></list-item></list></sec><sec id="s2-3-4-2"><title>Exclusion Criteria</title><p>Children were only excluded if they were unable to understand the study and provide assent.</p></sec></sec></sec><sec id="s2-4"><title>Participant Demographics</title><p>At each step, children and parents were directed to the relevant page on the website, viewed the corresponding animation, and then invited to join that step by clicking a link to the associated QuestionPro [<xref ref-type="bibr" rid="ref21">21</xref>] survey. Demographic data collected in these surveys included a parent&#x2019;s email address, the child&#x2019;s age, gender, country of residence, and ethnicity. The parents&#x2019; email address and the child&#x2019;s age were required fields, while gender, country of residence, and ethnicity were optional and were collected to assess the study&#x2019;s demographic and geographical reach, and, specifically, whether the decentralized design facilitated participation across different countries, age groups, and genders. Demographic data were collected for each survey except for the final 2, &#x201C;Collecting the results!&#x201D; and &#x201C;Sharing the results!&#x201D; as only previously participating children were invited to join those steps.</p></sec><sec id="s2-5"><title>Steps of the Kid&#x2019;s Trial</title><p>This section summarizes the purpose and methods of each step of The Kid&#x2019;s Trial<italic>.</italic> <xref ref-type="fig" rid="figure2">Figure 2</xref> illustrates the sequence and timeline of these steps. The duration of each step varied depending on operational requirements: &#x201C;Running the trial!&#x201D; and &#x201C;Collecting the results!&#x201D; remained open for the longest period to facilitate recruitment for the embedded RCT, whereas &#x201C;Sharing the results!&#x201D; was necessarily concise due to project deadlines.</p><fig position="float" id="figure2"><label>Figure 2.</label><caption><p>Timeline of The Kid&#x2019;s Trial surveys.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="jmir_v28i1e89240_fig02.png"/></fig><sec id="s2-5-1"><title>Pre-Trial Quiz: We Asked Children What They Already Knew About RCTs</title><p>The Pre-Trial Quiz included 3 simple questions about children&#x2019;s prior knowledge of RCTs. Participation in this survey was not mandatory in the remaining steps of The Kid&#x2019;s Trial, but children and parents were encouraged to complete this survey before proceeding to the other steps. This survey opened at the launch of The Kid&#x2019;s Trial (March 11, 2024) and remained open until September 16, 2025. This survey is available in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>.</p></sec><sec id="s2-5-2"><title>Choosing the Question: a 3-Part Process</title><p>The first step of The Kid&#x2019;s Trial aimed to identify which question we would try to answer with children worldwide. This step was divided into 3 parts. The 3 surveys that comprise the first step are available in <xref ref-type="supplementary-material" rid="app2">Multimedia Appendix 2</xref> (S2A sending in your questions survey, S2B sorting the questions survey, and S2C choosing the question survey).</p><sec id="s2-5-2-1"><title>Sending in Your Questions</title><p>The first survey of The Kid&#x2019;s Trial, &#x201C;Sending in your questions!&#x201D; was open from March 11, 2024, through May 26, 2024. This step invited children to submit fun, low-risk, health-related questions that they thought the study could address using a structured form (<xref ref-type="fig" rid="figure3">Figure 3</xref>). We provided examples of questions that could be tested, and children could use one of our examples or suggest their own.</p><fig position="float" id="figure3"><label>Figure 3.</label><caption><p>Survey 1 question submission form.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="jmir_v28i1e89240_fig03.png"/></fig><p>After submissions closed, we carried out a 3-stage question prioritization process because not all questions could be considered for The Kid&#x2019;s Trial. First, the research team reviewed each submitted question using the a priori inclusion criteria:</p><list list-type="order"><list-item><p>The question could not involve any medical interventions or testing, including dietary interventions.</p></list-item><list-item><p>The question was safe to test in an RCT, with no risks beyond children&#x2019;s everyday activities.</p></list-item><list-item><p>The question did not require special equipment (eg, gaming devices and specialized sporting equipment).</p></list-item><list-item><p>The question would not financially burden a family.</p></list-item><list-item><p>The question could be tested and answered within a short timeframe (approximately 1 week).</p></list-item></list><p>Next, we shared our initial decisions with the PPI groups, asking for their agreement or reasons for disagreement regarding the inclusion/exclusion of specific questions. Finally, the research team reviewed any disagreements and the justifications provided, and reached consensus on which questions would advance to the next step.</p></sec><sec id="s2-5-2-2"><title>Sorting the Questions</title><p>&#x201C;Sorting the questions!&#x201D; was open from June 11, 2024, through July 12, 2024. In this step, children told us how interested they were in answering the candidate questions that were submitted during the &#x201C;Sending in your questions!&#x201D; step. Their responses narrowed the list to 3 questions, which were carried forward into the final part of the first step: &#x201C;Choosing the question!&#x201D;</p></sec><sec id="s2-5-2-3"><title>Choosing the Question</title><p>&#x201C;Choosing the question!&#x201D; opened on July 16, 2024, and closed August 30, 2024. In this step, children selected and ranked their top 3 questions to select the final trial question: <italic>&#x201C;</italic>Does sleeping with a comfort item (for example, a soft toy or special blanket) make a difference to children&#x2019;s sleep compared with not sleeping with a comfort item?&#x201D; This question formed the basis of the randomized trial embedded within The Kid&#x2019;s Trial, which was called the REST trial. The intervention group (ie, sleeping with a comfort item) was called the &#x201C;Try-it-Out&#x201D; group, while the control group (ie, sleeping without a comfort item) was the &#x201C;Wait-and-See&#x201D; group.</p></sec></sec></sec><sec id="s2-6"><title>Planning the Trial: Children Help Design the Trial</title><p>Between September 4, 2024, and November 18, 2024, children were invited to join the second step of The Kid&#x2019;s Trial, in which children were asked to plan the trial that would address their selected question. They determined both the primary and secondary outcomes for the REST trial and the treatment arm procedures for participation in the &#x201C;Try-it-Out&#x201D; and &#x201C;Wait-and-See&#x201D; groups. To identify the outcomes, children were asked how sleep quality should be measured after the trial. They could select more than one of the following options:</p><list list-type="order"><list-item><p>Children completed an online survey the day after they finished their trial, reporting how their nighttime sleep was.</p></list-item><list-item><p>Children completed an online survey the day after they finished their trial, reporting how sleepy they felt during the day.</p></list-item><list-item><p>Children completed an online survey the day after they finished their trial, reporting how well they thought they had slept overall.</p></list-item></list><p>The 2 most popular options helped identify the primary and secondary outcomes for the REST trial. To identify the primary outcome, we asked which outcome best showed how children slept. Children selected daytime sleepiness as the primary outcome and overall sleep quality as the secondary outcome.</p><p>To define treatment and control arm procedures, the children were asked:</p><list list-type="order"><list-item><p>Should kids in both groups sleep in their usual beds for the entire trial?</p></list-item><list-item><p>Should kids in the &#x201C;Try-it-Out&#x201D; group use the same comfort item every night, or could they switch items?</p></list-item><list-item><p>When should kids in the &#x201C;Try-it-Out&#x201D; group start using their comfort item each night?</p></list-item></list><p>Children&#x2019;s &#x201C;usual beds&#x201D; were defined as any bed where they regularly sleep, for example at home, at a relative&#x2019;s house, or in another regular residence. The &#x201C;Planning the trial!&#x201D; survey is available in <xref ref-type="supplementary-material" rid="app3">Multimedia Appendix 3</xref></p></sec><sec id="s2-7"><title>Running the Trial: Children Join the Trial That They Created</title><p>In &#x201C;Running the trial!&#x201D; children were invited to take part in the REST trial. By clicking the &#x201C;Join the trial here!&#x201D; button on the website, children were redirected to a QuestionPro survey [<xref ref-type="bibr" rid="ref21">21</xref>], in which baseline data on daytime sleepiness and overall sleep quality were collected before randomization. This step opened on January 16, 2025, and closed September 15, 2025.</p><p>Daytime sleepiness was measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Short Form v1.0 Sleep-Related Impairment 4a [<xref ref-type="bibr" rid="ref26">26</xref>], which yields a standardized T-score, with lower scores indicating less impairment [<xref ref-type="bibr" rid="ref27">27</xref>,<xref ref-type="bibr" rid="ref28">28</xref>]. Overall sleep quality was measured with the single-item Sleep Quality Scale (SQS) [<xref ref-type="bibr" rid="ref29">29</xref>]. The SQS instrument consists of one question that asks participants to rate their overall sleep quality over the previous 7 days on a categorical scale coded 1&#x2010;5, with higher scores indicating better sleep quality [<xref ref-type="bibr" rid="ref29">29</xref>].</p><p>The REST trial was a 2-arm, parallel-group, pragmatic superiority RCT. The intervention period lasted one week, and participants were randomized using a 1:1 ratio to either the &#x201C;Try-it-Out&#x201D; or &#x201C;Wait-and-See&#x201D; group using computer-generated randomization using QuestionPro [<xref ref-type="bibr" rid="ref21">21</xref>]. Due to resource constraints, it was not possible to engage an independent researcher to clean and manage the data; consequently, the researchers became aware of group allocation after participant randomization. Because of the nature of the intervention, it was impossible to blind participants to their group. However, no party could influence or predict a participants&#x2019; group allocation. This survey is available in <xref ref-type="supplementary-material" rid="app4">Multimedia Appendix 4</xref>.</p></sec><sec id="s2-8"><title>Collecting the Results: Children Tell Us the Results of Their Trial</title><p>In the fourth step, &#x201C;Collecting the results!&#x201D; parents of children who took part in the REST trial received an email with a survey link specific to their child&#x2019;s allocated group 8 days after randomization. These surveys collected primary (sleep-related impairment [SRI]) and secondary (SQS) outcome data, along with additional group-specific questions on intervention adherence. These adherence data are reported in the REST trial report [<xref ref-type="bibr" rid="ref30">30</xref>]. If the survey was not completed within 10 days postrandomization, a reminder email was sent, followed by a final reminder on day 13 postrandomization. These surveys are available in <xref ref-type="supplementary-material" rid="app5">Multimedia Appendix 5</xref> (S5A and S5B).</p><p>The REST trial protocol [<xref ref-type="bibr" rid="ref31">31</xref>], statistical analysis plan (SAP) [<xref ref-type="bibr" rid="ref32">32</xref>], and full trial report [<xref ref-type="bibr" rid="ref30">30</xref>] detail the methods, analyses performed, and full results. Analyses followed an intention-to-treat (ITT) approach using a mixed effects model with treatment group as the main predictor, adjusting for baseline outcome, baseline comfort item use, age, and gender as fixed effects and country of residence as a random effect. Additionally, exploratory subgroup and sensitivity analyses were conducted as outlined in the SAP to assess differences by baseline characteristics.</p></sec><sec id="s2-9"><title>Sharing the Results: Children Decide How and Where to Share the Results of the Trial</title><p>In &#x201C;Sharing the results!&#x201D; all parents whose children had previously participated in any step of The Kid&#x2019;s Trial received an email inviting their children to rank different methods and locations in which to share the study results. This step opened on September 16, 2025, and closed on October 9, 2025. To determine which options children would rank, the research team first consulted the PPI groups to ensure the choices were appropriate and gather additional suggestions.</p><p>Additionally, this survey repeated the 3 questions from the Pre-Trial Quiz to assess children&#x2019;s understanding of RCTs and learning gained through participation. Finally, children were asked about their experience of taking part in The Kid&#x2019;s Trial and their views on the learning materials. This survey is available in <xref ref-type="supplementary-material" rid="app6">Multimedia Appendix 6</xref>.</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><sec id="s3-1"><title>Participation and Demographics</title><p>Participation across the steps of The Kid&#x2019;s Trial is summarized in <xref ref-type="fig" rid="figure4">Figure 4</xref>. In total, 224 children from 15 countries took part in at least one survey (<xref ref-type="fig" rid="figure4">Figure 4A</xref>). The number of participants per survey ranged from 20 to 166. The optional Pre-Trial Quiz had the highest participation (n=166), followed by &#x201C;Running the trial!&#x201D; (n=139) and &#x201C;Collecting the results!&#x201D; (n=101). The earlier surveys (&#x201C;Sending in your questions!&#x201D; &#x201C;Sorting the questions!&#x201D; &#x201C;Choosing the question!&#x201D; and &#x201C;Planning the trial!&#x201D;) had lower participation counts (24, 63, 64, and 65 participants, respectively).</p><fig position="float" id="figure4"><label>Figure 4.</label><caption><p>Overall participation across surveys and the combinations of surveys participants completed.A) Number of participants completing each survey. (B) Number of participants completing each combination of surveys. (C) Surveys included in each completion combination.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="jmir_v28i1e89240_fig04.png"/></fig><p><xref ref-type="fig" rid="figure4">Figure 4B and C</xref> illustrate how participation overlapped across steps. <xref ref-type="fig" rid="figure4">Figure 4B</xref> shows the number of children who completed each unique combination of surveys, ordered from the most common (left) to the least common (right). Each bar represents a specific participation pattern. <xref ref-type="fig" rid="figure4">Figure 4C</xref> visualizes these combinations: filled circles indicate the surveys completed for each pattern, while empty circles show surveys not completed. Together, these plots reveal that 37% (n=82) completed only one survey, 19% (n=42) completed two, 15% (n=33) completed three, 6% (n=14) completed four, 0.9% (n=2) completed five surveys, and 21% (n=48) completed six surveys. Only 0.4% (n=1) completed seven surveys, and 0.9% (n=2) completed all eight. The most common participation patterns involved combinations of the trial-conducting steps (&#x201C;Running the trial!&#x201D; and &#x201C;Collecting the results!) with or without the Pre-Trial Quiz.</p><p>The mean age of participants was 9.3 (SD 1.6) years. Most parents reported their child&#x2019;s gender; 55% (n=122) listed &#x201C;boy,&#x201D; 45% (n=101) listed &#x201C;girl,&#x201D; 0.4% (n=1) selected &#x201C;prefer not to answer,&#x201D; and no parents selected &#x201C;something not listed here.&#x201D; Most parents provided their child&#x2019;s country of residence (99%, n=222) and ethnicity (98%, n=219). Of those, approximately 10% (n=20) chose to specify ethnicity in a free-text response. Most participants lived in Ireland (44%, n=98) or Kenya (39%, n=87). Most parents listed &#x201C;White&#x201D; (53%, n=116) as their child&#x2019;s ethnicity, and 34% (n=75) listed &#x201C;Black/Black Irish.&#x201D; Detailed demographic information of participating children is presented in <xref ref-type="table" rid="table1">Table 1</xref>.</p><table-wrap id="t1" position="float"><label>Table 1.</label><caption><p>Demographics of all participants in The Kid&#x2019;s Trial. Percentages use nonmissing responses as the denominator for each characteristic.</p></caption><table id="table1" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Characteristic (N=224)</td><td align="left" valign="bottom">Values</td></tr></thead><tbody><tr><td align="left" valign="top">Age (years), n (%)</td><td align="left" valign="top">224 (100)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>7</td><td align="left" valign="top">38 (17.0)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>8</td><td align="left" valign="top">33 (14.7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>9</td><td align="left" valign="top">53 (23.7)</td></tr><tr><td align="char" char="." valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>10</td><td align="left" valign="top">42 (18.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>11</td><td align="left" valign="top">36 (16.1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>12</td><td align="left" valign="top">22 (9.8)</td></tr><tr><td align="left" valign="top">Gender, n (%)</td><td align="left" valign="top">224 (100)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Boy</td><td align="left" valign="top">122 (54.5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Girl</td><td align="left" valign="top">101 (45.1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Prefer not to answer</td><td align="left" valign="top">1 (0.4)</td></tr><tr><td align="left" valign="top">Country of residence</td><td align="left" valign="top">222 (100)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Ireland</td><td align="left" valign="top">98 (44.1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Kenya</td><td align="left" valign="top">87 (39.2)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>United Kingdom</td><td align="left" valign="top">15 (6.8)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>United States</td><td align="left" valign="top">5 (2.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Australia</td><td align="left" valign="top">3 (1.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Germany</td><td align="left" valign="top">3 (1.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Estonia</td><td align="left" valign="top">2 (0.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>India</td><td align="left" valign="top">2 (0.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Austria</td><td align="left" valign="top">1 (0.5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Italy</td><td align="left" valign="top">1 (0.5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Mexico</td><td align="left" valign="top">1 (0.5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Northern Ireland</td><td align="left" valign="top">1 (0.5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Pakistan</td><td align="left" valign="top">1 (0.5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Singapore</td><td align="left" valign="top">1 (0.5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Switzerland</td><td align="left" valign="top">1 (0.5)</td></tr><tr><td align="left" valign="top">Ethnicity, n (%)</td><td align="left" valign="top">219 (100)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>White</td><td align="left" valign="top">116 (53.0)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Black/Black Irish</td><td align="left" valign="top">75 (34.2)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other/Mixed</td><td align="left" valign="top">21 (9.6)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Asian/Asian Irish</td><td align="left" valign="top">7 (3.2)</td></tr><tr><td align="left" valign="top">Specific ethnic group, n (%)</td><td align="left" valign="top">170 (100)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Irish</td><td align="left" valign="top">68 (40.0)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>African</td><td align="left" valign="top">66 (38.8)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>White other</td><td align="left" valign="top">15 (8.8)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Mixed</td><td align="left" valign="top">11 (6.5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other</td><td align="left" valign="top">4 (2.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Asian other</td><td align="left" valign="top">2 (1.2)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Indian/Pakistani/Bangladeshi</td><td align="left" valign="top">2 (1.2)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Chinese</td><td align="left" valign="top">1 (0.6)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Traveler</td><td align="left" valign="top">1 (0.6)</td></tr><tr><td align="left" valign="top">Ethnicity free-text (n)</td><td align="left" valign="top">20 (100)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Asian Irish</td><td align="left" valign="top">2 (10)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Luo</td><td align="left" valign="top">2 (10)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>White and Asian</td><td align="left" valign="top">2 (10)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>American</td><td align="left" valign="top">1 (5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>British</td><td align="left" valign="top">1 (5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Canadian Irish</td><td align="left" valign="top">1 (5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Half British Australian/half Romanian</td><td align="left" valign="top">1 (5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Indian</td><td align="left" valign="top">1 (5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Indonesian</td><td align="left" valign="top">1 (5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Kenyan</td><td align="left" valign="top">1 (5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Kikuyu</td><td align="left" valign="top">1 (5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Mexicano</td><td align="left" valign="top">1 (5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Slovak and Latin American</td><td align="left" valign="top">1 (5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sri Lankan</td><td align="left" valign="top">1 (5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>White and Black</td><td align="left" valign="top">1 (5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>White and Black Caribbean</td><td align="left" valign="top">1 (5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>White and Eastern European</td><td align="left" valign="top">1 (5)</td></tr></tbody></table></table-wrap></sec><sec id="s3-2"><title>Recruitment</title><sec id="s3-2-1"><title>Overview</title><p>Recruitment sources for The Kid&#x2019;s Trial are shown in <xref ref-type="fig" rid="figure5">Figure 5</xref>. Of the 224 participants, the largest number was recruited through schools (44%, n=98), either via flyers circulated in Irish schools or through a Kenyan children&#x2019;s charity, Toto Centre Initiative, which shared information about the study with local schools. Referrals from family, friends, or coworkers (14%, n=32) and social media or radio interviews (11%, n=25, each) were the next most effective recruitment avenues. Paid advertising increased website traffic but did not translate into participant enrollment.</p><fig position="float" id="figure5"><label>Figure 5.</label><caption><p>Recruitment sources for The Kid&#x2019;s Trial.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="jmir_v28i1e89240_fig05.png"/></fig></sec><sec id="s3-2-2"><title>Pre-Trial Quiz</title><p>Across the course of The Kid&#x2019;s Trial, 166 children completed the Pre-Trial Quiz. This likely reflects that the survey remained open throughout The Kid&#x2019;s Trial (<xref ref-type="fig" rid="figure2">Figure 2</xref>) to capture baseline knowledge of RCTs from participants joining at different stages of the study. The majority of children who completed this survey felt they understood what randomized trials were (70%, n=117), why they mattered (72%, n=120), and how they were conducted (60%, n=99).</p></sec><sec id="s3-2-3"><title>Choosing the Question: Children Chose the Trial Question</title><p>In the first part of the question identification process, 24 children submitted questions they wanted to test in an RCT. After applying the inclusion criteria and PPI review, 9 questions were considered candidate questions for The Kid&#x2019;s Trial. The full list of questions, along with the reasons for inclusion or exclusion, was published on the website and can be found in <xref ref-type="supplementary-material" rid="app7">Multimedia Appendix 7</xref>.</p><p>In &#x201C;Sorting the questions!&#x201D; 63 children reviewed the 9 candidate questions by completing a survey that used a 3-point Likert scale illustrated with emoji faces and corresponding text labels: &#x201C;Yes, please. I&#x2019;m interested in answering this question,&#x201D; &#x201C;I&#x2019;m not sure about this question,&#x201D; and &#x201C;No, I&#x2019;m not interested in answering this question.&#x201D; The &#x201C;Yes&#x2026;&#x201D; and &#x201C;I&#x2019;m not sure&#x2026;&#x201D; votes were combined to determine the top 3 questions. <xref ref-type="fig" rid="figure6">Figure 6</xref> presents the results of this survey, in which &#x201C;Does sleeping with a comfort item (for example, a soft toy or special blanket) make a difference to kids&#x2019; sleep?&#x201D; (n=59 summed votes), &#x201C;Does listening to music while exercising make exercising more fun for kids compared to not listening to music while exercising?&#x201D; (n=57 summed votes), and &#x201C;Does listening to mindful music before bed make a difference to how well kids sleep compared to not listening to mindful music before bed?&#x201D; (n=54 summed votes) were the 3 highest-ranked questions.</p><p>In &#x201C;Choosing the question!&#x201D; 64 children ranked the top 3 questions and 73% (n=47) selected &#x201C;Does sleeping with a comfort item (for example, a soft toy or special blanket) make a difference to children&#x2019;s sleep compared with not sleeping with a comfort item?&#x201D; as their favorite question.</p><fig position="float" id="figure6"><label>Figure 6.</label><caption><p>Results of &#x201C;Sorting the questions!&#x201D;</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="jmir_v28i1e89240_fig06.png"/></fig></sec><sec id="s3-2-4"><title>Planning the Trial: Children Co-Designed the Trial</title><p>Sixty-five children took part in this survey to choose the outcomes of the trial and parameters of the &#x201C;Try-it-Out&#x201D; and &#x201C;Wait-and-See&#x201D; groups. Children decided that participants in the &#x201C;Try-it-Out&#x201D; group would:</p><list list-type="order"><list-item><p>Sleep with the same comfort item each night of the trial.</p></list-item><list-item><p>Start using their comfort item when they are getting ready for bed each night of the trial.</p></list-item><list-item><p>Sleep in their &#x201C;usual&#x201D; bed for the duration of the trial.</p></list-item><list-item><p>Keep everything else the same as normal in their bedtime routine each night of the trial.</p></list-item></list><p>The participants in the &#x201C;Wait-and-See&#x201D; group would:</p><list list-type="order"><list-item><p>Not use any comfort item each night.</p></list-item><list-item><p>Sleep in their &#x201C;usual&#x201D; bed each night.</p></list-item><list-item><p>Keep everything else in their bedtime routine the same as normal each night.</p></list-item></list><p>Children selected daytime sleepiness (40%, n=26) as the primary outcome and overall sleep quality (32%, n=21) as the secondary outcome. The full results of this survey are available in <xref ref-type="supplementary-material" rid="app8">Multimedia Appendix 8</xref>.</p></sec><sec id="s3-2-5"><title>Running the Trial: Who Joined the REST Trial?</title><p>The REST trial aimed to recruit 292 children to determine whether sleeping with a toy or comfort item affects children&#x2019;s sleep compared with not sleeping with one. Details of how we calculated the sample size are available in the SAP [<xref ref-type="bibr" rid="ref32">32</xref>] and the trial protocol [<xref ref-type="bibr" rid="ref31">31</xref>]. Despite recruitment strategies and extending the planned 6-month recruitment period by 3 months, we were unable to reach this target. In total, 139 children from 11 countries were randomized (72 to the &#x201C;Wait-and-See,&#x201D; and 67 to the &#x201C;Try-it-Out&#x201D; group). <xref ref-type="table" rid="table2">Table 2</xref> presents the baseline data for children enrolled in the REST trial. The mean age of participants was 9.8 (SD = 1.6) years, and 54% (n=76) were girls. At baseline, most children (80%, n=110) used a comfort item &#x201C;Sometimes&#x201D; or &#x201C;Always.&#x201D; At baseline, the overall mean SRI T-score was 51.38 (SD 7.94), and the overall mean SQS score was 3.76 (SD 0.81). These scores were similar across arms.</p><table-wrap id="t2" position="float"><label>Table 2.</label><caption><p>Baseline data of children who joined the Randomized Evaluation of Sleeping with a Toy or comfort item (REST) trial. Percentages use nonmissing responses as denominators.</p></caption><table id="table2" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Characteristics</td><td align="left" valign="bottom" colspan="3">Variables</td></tr></thead><tbody><tr><td align="left" valign="top"/><td align="left" valign="top">Overall (n=139)</td><td align="left" valign="top">Control (n=72)</td><td align="left" valign="top">Intervention (n=67)</td></tr><tr><td align="left" valign="top">Age (years), mean (SD)</td><td align="left" valign="top">9.8 (1.6)</td><td align="left" valign="top">9.8 (1.6)</td><td align="left" valign="top">9.8 (1.6)</td></tr><tr><td align="left" valign="top">Age (years), n (%)</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>7</td><td align="left" valign="top">16 (11.5)</td><td align="left" valign="top">8 (11.1)</td><td align="left" valign="top">8 (11.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>8</td><td align="left" valign="top">16 (11.5)</td><td align="left" valign="top">8 (11.1)</td><td align="left" valign="top">8 (11.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>9</td><td align="left" valign="top">27 (19.4)</td><td align="left" valign="top">17 (23.6)</td><td align="left" valign="top">10 (14.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>10</td><td align="left" valign="top">31 (22.3)</td><td align="left" valign="top">12 (16.7)</td><td align="left" valign="top">19 (28.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>11</td><td align="left" valign="top">24 (17.3)</td><td align="left" valign="top">14 (19.4)</td><td align="left" valign="top">10 (14.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>12</td><td align="left" valign="top">25 (18.0)</td><td align="left" valign="top">13 (18.1)</td><td align="left" valign="top">12 (17.9)</td></tr><tr><td align="left" valign="top">Gender, n (%)</td><td align="left" valign="top">&#x2003;</td><td align="left" valign="top">&#x2003;</td><td align="left" valign="top">&#x2003;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Boy</td><td align="left" valign="top">63 (45.3)</td><td align="left" valign="top">33 (45.8)</td><td align="left" valign="top">30 (44.8)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Girl</td><td align="left" valign="top">76 (54.7)</td><td align="left" valign="top">39 (54.2)</td><td align="left" valign="top">37 (55.2)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Something not listed here</td><td align="left" valign="top">&#x2014;<sup><xref ref-type="table-fn" rid="table2fn1">a</xref></sup></td><td align="left" valign="top">0 (0.0)</td><td align="left" valign="top">0 (0.0)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Prefer not to answer</td><td align="left" valign="top">&#x2014;</td><td align="left" valign="top">0 (0.0)</td><td align="left" valign="top">0 (0.0)</td></tr><tr><td align="left" valign="top">Usual comfort-item use at baseline, n (%)</td><td align="left" valign="top">&#x2003;</td><td align="left" valign="top">&#x2003;</td><td align="left" valign="top">&#x2003;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Never</td><td align="left" valign="top">29 (20.9)</td><td align="left" valign="top">15 (20.8)</td><td align="left" valign="top">14 (20.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Sometimes</td><td align="left" valign="top">48 (34.5)</td><td align="left" valign="top">30 (41.7)</td><td align="left" valign="top">18 (26.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Always</td><td align="left" valign="top">62 (44.6)</td><td align="left" valign="top">27 (37.5)</td><td align="left" valign="top">35 (52.2)</td></tr><tr><td align="left" valign="top">Sleep-Related Impairment T-Score<sup><xref ref-type="table-fn" rid="table2fn2">b</xref></sup>, mean (SD)</td><td align="left" valign="top">51.4 (7.9)</td><td align="left" valign="top">51.2 (7.7)</td><td align="left" valign="top">51.5 (8.2)</td></tr><tr><td align="left" valign="top">Sleep quality, mean (SD)</td><td align="left" valign="top">3.8 (0.8)</td><td align="left" valign="top">3.8 (0.8)</td><td align="left" valign="top">3.7 (0.8)</td></tr></tbody></table><table-wrap-foot><fn id="table2fn1"><p><sup>a</sup>Not applicable.</p></fn><fn id="table2fn2"><p><sup>b</sup>Sleep-Related Impairment T-Score (lower=less impairment).</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3-2-6"><title>Collecting the Results: Did Sleeping With a Comfort Item Affect Children&#x2019;s Sleep?</title><p>Of the 139 children randomized in the REST trial, 101 completed their posttrial surveys, resulting in an attrition rate of approximately 27%. <xref ref-type="fig" rid="figure7">Figure 7</xref> shows the CONSORT (Consolidated Standards of Reporting Trials) [<xref ref-type="bibr" rid="ref33">33</xref>] participant flow diagram of the REST trial.</p><fig position="float" id="figure7"><label>Figure 7.</label><caption><p>The Randomized Evaluation of Sleeping With a Toy or Comfort Item (REST) trial participant flow diagram.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="jmir_v28i1e89240_fig07.png"/></fig><p>Adjusting for baseline outcome, baseline comfort-item use, age, and gender as fixed effects and country of residence as a random effect, the mean difference in SRI T-scores was &#x2212;0.53 (95% CI &#x2212;3.40 to 2.34; <italic>P</italic>=.71), indicating no meaningful effect on sleep-related impairment. The adjusted mean difference in SQS was 0.28 (95% CI 0.01-0.55; <italic>P</italic>=.04), representing a small, uncertain improvement in perceived sleep quality that was not maintained in per-protocol analyses. Multiple imputation and sensitivity analyses for the primary and secondary outcomes yielded consistent conclusions. No adverse events were reported. The primary analysis results from the REST trial are presented in <xref ref-type="table" rid="table3">Table 3</xref>. Full details of the trial&#x2019;s methods and results are available elsewhere [<xref ref-type="bibr" rid="ref30">30</xref>].</p><table-wrap id="t3" position="float"><label>Table 3.</label><caption><p>Results of the primary analysis of the primary and secondary outcomes of the Randomized Evaluation of Sleeping With a Toy or Comfort Item (REST) trial. Models adjust for baseline outcome, baseline comfort-item use, age, and gender;, with random intercept for collapsed country.</p></caption><table id="table3" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom" colspan="2">POutcome and grouprimary analysis (ITT): adjusted means at follow-up and adjusted differences</td><td align="left" valign="bottom" colspan="2">Primary analysis (ITT):<sup><xref ref-type="table-fn" rid="table3fn1">a</xref></sup> adjusted means at follow-up and adjusted differences</td></tr><tr><td align="left" valign="top" colspan="2">Outcome and group</td><td align="left" valign="top">Adjusted mean (95% CI)</td><td align="left" valign="top"><italic>P</italic> value</td></tr></thead><tbody><tr><td align="left" valign="top" colspan="2">SRI<sup><xref ref-type="table-fn" rid="table3fn2">b</xref></sup> (lower=better<bold>)</bold></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Control</td><td align="left" valign="top">47.73 (45.77 to 49.68)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Intervention</td><td align="left" valign="top">47.20 (45.10 to 49.30)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Difference (Intervention &#x2013; Control)</td><td align="left" valign="top">&#x2212;0.53 (&#x2212;3.4 to 2.34)</td><td align="left" valign="top">.71</td></tr><tr><td align="left" valign="top" colspan="2">SQS<sup><xref ref-type="table-fn" rid="table3fn3">c</xref></sup> (higher=better)</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Control</td><td align="left" valign="top">3.71 (3.52 to 3.89)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Intervention</td><td align="left" valign="top">3.99 (3.79 to 4.19)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Difference (intervention &#x2013; control)</td><td align="left" valign="top">0.28 (0.01 to 0.55)</td><td align="left" valign="top">.04</td></tr></tbody></table><table-wrap-foot><fn id="table3fn1"><p><sup>a</sup> ITT: intention-to-treat. All randomized participants with posttest outcomes.</p></fn><fn id="table3fn2"><p><sup>b</sup>SRI: sleep-related impairment . Lower=less impairment (better).</p></fn><fn id="table3fn3"><p><sup>c</sup>SQS: sleep quality scale. Higher=better sleep quality.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3-2-7"><title>Sharing the Results: Children Choose How to Share the Results of the Kid&#x2019;s Trial</title><p>Of the 224 children invited, 20 children (9%) completed this survey. The 2 most popular ways to share the results of The Kid&#x2019;s Trial were an animated video (50%, n=10) and charts and graphs (30%, n=6). The most popular places to share the results were The Kid&#x2019;s Trial website (60%, n=12) and The Kid&#x2019;s Trial YouTube channel (20%, n=4).</p><p>This survey also asked children the same questions that the Pre-Trial Quiz asked about their knowledge of RCTs. Of the 20 children who completed the final survey, 11 also completed the Pre-Trial Quiz. Their wider participation patterns are shown in <xref ref-type="fig" rid="figure4">Figure 4</xref>. Because posttrial survey completion was low, the data were insufficient for meaningful comparison with pretrial responses, and no statistical analyses were undertaken. However, of the 20 children who did answer these questions, all participants said they understood what randomized trials were and how they were conducted, and 90% (n=18) said they understood why they mattered.</p><p>Finally, we asked how children viewed participating in The Kid&#x2019;s Trial and the materials on the website. Most children enjoyed taking part (95%, n=19), found the videos (85%, n=17) and written information (70%, n=14) on the website helpful, and said their interest in health research was increased (75%, n=15) due to taking part in The Kid&#x2019;s Trial. The full results of this survey are available in S9 in <xref ref-type="supplementary-material" rid="app9">Multimedia Appendix 9</xref>.</p></sec></sec></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><sec id="s4-1"><title>Principal Findings</title><p>The Kid&#x2019;s Trial demonstrated that a global, child-led citizen science RCT can be conducted using a fully decentralized design. Children engaged across multiple stages of the research process, including choosing a research question, defining trial procedures, participating in the trial, and choosing how the findings would be shared. While recruitment for the REST trial fell short of its target and attrition was higher than expected, the successful completion of all study steps and overall engagement of 224 children and families demonstrates that children can meaningfully contribute to core trial activities within a fully online RCT. These findings highlight key methodological and practical considerations for designing and conducting participatory, decentralized trials with children.</p><p>The embedded REST trial found no meaningful effect of comfort items on sleep-related impairment, with a small improvement in perceived sleep quality that was not robust to sensitivity analyses. These findings should be interpreted in the context of an underpowered study. As such, the REST trial is best understood as a proof-of-concept that demonstrates the implementation of a child-led, decentralized RCT, rather than providing definitive evidence on the effect of comfort items on the quality of children&#x2019;s sleep. While the trial findings were inconclusive, the successful conduct of a participatory, child-led trial, demonstrated by children&#x2019;s participation across all steps, illustrates that children can meaningfully engage with the process of generating, refining, and testing research questions. It also highlights that participation in these processes can provide opportunities for children to learn an important principle: not all interventions show effects, and learning to interpret null or uncertain findings is an important aspect of critical appraisal.</p><p>By adapting the principles of public co-production for a younger audience, The Kid&#x2019;s Trial extends the approach pioneered by The People&#x2019;s Trial [<xref ref-type="bibr" rid="ref9">9</xref>]. Like its predecessor, it used experiential participation to engage children with RCT processes, aligning with educational frameworks that emphasize active participation as central to learning [<xref ref-type="bibr" rid="ref34">34</xref>]. Children&#x2019;s engagement throughout the study supports previous research showing that inquiry-based participation fosters curiosity and critical thinking about science and health [<xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref35">35</xref>,<xref ref-type="bibr" rid="ref36">36</xref>]. Importantly, the study also provided researchers with practical insight into how children can be active partners in health literacy and research engagement initiatives, rather than passive recipients of information. Involving children in the co-creation of the trial meant that they chose the research question, selected and prioritized outcomes, contributed to trial procedures, and selected dissemination routes according to their own priorities and perspectives. As a result, The Kid&#x2019;s Trial reflects children&#x2019;s interests and decision-making processes in ways that may have differed substantially from an adult-designed study.</p><p>One of the aims of The Kid&#x2019;s Trial was to explore whether participation in a co-created RCT could improve children&#x2019;s engagement with and understanding of trials. The limited posttrial results are consistent with respondents&#x2019; perceived improvements in RCT understanding. These findings should be interpreted cautiously, given the small number of posttrial responses and potential self-selection bias, but they are consistent with the broader educational rationale underpinning participatory approaches.</p><p>It is important, however, to distinguish between the dual objectives of The Kid&#x2019;s Trial. While the study successfully engaged children in an experiential citizen-science initiative, the embedded REST trial fell short of its recruitment target, was underpowered for its primary analysis, and yielded null or uncertain findings. These dual outcomes underscore the tension in citizen science between rigorous scientific methods and broad public engagement. While this tension is not unique to our study, it highlights the importance of clearly defining success criteria at the outset: for educational citizen-science initiatives, engagement and learning outcomes may be more relevant benchmarks than statistical power or definitive scientific conclusions.</p><p>Participation patterns showed considerable variability but demonstrated that sustained engagement in a multistep online study is achievable for children in this age group. Because the final survey sample was small, we did not attempt demographic comparisons between early- and late-stage completers. While many participants engaged briefly, a meaningful subset remained active across several stages, particularly during the trial conduct steps. Children and parents appeared to be most motivated by concrete, action-oriented activities such as running the trial and reporting results, with fewer joining the earlier planning steps. This likely reflects a combination of factors, including the intensified recruitment efforts during that period and increased awareness of the study after several months of ongoing advertising and dissemination of materials. This pattern suggests future studies should consider a &#x201C;core-periphery&#x201D; design that distinguishes between essential trial-conduct steps (which attract higher engagement) and optional enrichment activities (for sustained participants). Alternatively, condensing all steps into a shorter, more intensive timeframe might preserve momentum, though this would need to be balanced against the cognitive and time demands on child participants.</p><p>Recruitment for The Kid&#x2019;s Trial proved challenging despite extensive and varied outreach. The intentionally wide target population, chosen to maximize inclusivity, may have reduced the personal relevance or urgency that drives participation in more narrowly focused studies, particularly given the many competing demands on families&#x2019; schedules. Additionally, the lack of established school or community partner networks limited the reach of the recruitment effort. The REST trial&#x2019;s extended recruitment period (9 vs 6 months) may have contributed to attrition, as delays between steps reduced continuity and momentum. The final step, &#x201C;Sharing the results!&#x201D; was open for only 2 weeks due to study deadlines, which may have further contributed to the low participation at that stage. The decline to only 9% completion in the final step raises important questions about study design. While the abbreviated timeframe was a contributing factor, this attrition likely also reflects cumulative fatigue, the absence of personal relevance of disseminating the outcome, and the substantial time elapsed since randomization (up to 9 months for early participants). Future studies might maintain engagement by integrating dissemination planning earlier, offering multiple dissemination formats throughout the study, or creating milestone celebrations to sustain momentum. The low response rate also prevented robust assessment of learning outcomes, limiting our ability to evaluate whether participation meaningfully improved trial literacy, a core objective of the initiative.</p><p>Notably, paid digital advertising increased website traffic but failed to convert visitors to participants, suggesting that trust and personal connection, rather than visibility alone, drive enrollment in child-focused citizen science. This finding has practical implications for future resource allocation, suggesting that investment in community partnerships and institutional networks may yield better returns than paid advertising.</p><p>Despite these challenges, the study demonstrates the feasibility of this approach. Early and sustained involvement of PPI groups ensured that study materials were age-appropriate and engaging. The decentralized model allowed participation across cultural and geographic contexts at relatively low cost, showing that such designs can enhance inclusion and accessibility in child-focused research.</p></sec><sec id="s4-2"><title>Strengths and Limitations</title><p>The Kid&#x2019;s Trial had several notable strengths. It is, to our knowledge, the first global citizen-science RCT co-created and conducted by children, integrating authentic public involvement throughout the trial. The decentralized design allowed participation from 15 countries without prespecified geographic limitations. However, participation was heavily concentrated in 2 countries (Ireland and Kenya, representing 83% of participants), reflecting the research team&#x2019;s networks and the successful partnership with Toto Centre Initiative in Kenya. While the study achieved international reach, future work should distinguish between &#x201C;global access&#x201D; and &#x201C;global engagement&#x201D; when describing decentralized studies. The extensive PPI input enhanced the study&#x2019;s relevance and child-centered design, and the trial materials, including the animations, simplified complex trial concepts, making them accessible and engaging for children.</p><p>However, the limitations should also be acknowledged. The online format excludes children without internet access, estimated at up to one-third of the global population [<xref ref-type="bibr" rid="ref37">37</xref>]. At the same time, the decentralized format may offer opportunities to engage children who are geographically dispersed or less connected to traditional research settings, particularly when combined with community-based partnerships. The reliance on parental support and the use of English-only materials also limited inclusivity. Although our work with the CRAG members enhanced the accessibility and child-friendly tone of study materials, the study did not address the needs of children with additional communication or learning requirements. In addition, we did not collect children&#x2019;s literacy or parents&#x2019; education levels among PPI group members, which limits how fully we can describe the advisory groups&#x2019; educational and literacy context or assess whether further adaptations were needed. Future work should explore how participatory trials can be adapted to support a wider range of access needs, for example, through easy-read or multilingual materials, additional visual supports, hybrid delivery options, and accessibility testing with children at the younger end of the age range.</p><p>The REST trial was underpowered, and its outcomes and children&#x2019;s understanding of RCTs was self-reported. Because participants were aware of their allocated group and outcomes were self-reported, the REST trial was also vulnerable to expectancy and social desirability biases. This may have influenced the outcome measures, such as perceived sleep quality, particularly given that the small between-group difference in SQS was not robust to sensitivity analyses. Posttrial data were limited to 20 responses (9% of participants), and although all respondents reported understanding what RCTs were and how they were conducted, compared with 70% and 60% at baseline, respectively, these findings require cautious interpretation, given the small sample size and potential selection bias (those who completed the final survey may have been more engaged learners). Rather than providing definitive evidence of learning, these results are consistent with the possibility that experiential participation may support children&#x2019;s perceived understanding of trial concepts and their importance. Future studies should prioritize learning assessment by embedding brief knowledge checks throughout the study rather than relying solely on final surveys, and by using validated instruments where available.</p></sec><sec id="s4-3"><title>Conclusions</title><p>The Kid&#x2019;s Trial provides proof-of-concept that children can meaningfully contribute to the design and conduct of an RCT through a fully decentralized participatory approach. It highlights both the potential and the practical challenges of involving children as research partners. By introducing trial literacy through experiential participation, the study suggests that children can begin to engage critically with evidence from an early age through active participation in generating and testing research questions.</p><p>Future child-led citizen-science studies could improve this model by prioritizing early partnerships with schools and community organizations, which proved the most effective recruitment channel in the present study (44% of participants), rather than relying on social media or paid advertising, which generated traffic but failed to convert visitors to participants. Condensing study phases to maintain momentum between steps (limiting intervals to 4&#x2010;6 weeks rather than the months-long gaps in our timeline) and integrating brief learning assessments throughout rather than only at the end point would address the substantial attrition observed in later stages. Researchers should also clearly distinguish between educational outcomes (engagement, interest, and satisfaction) and scientific outcomes (statistical power and definitive findings) when defining success metrics, as these dual objectives may require different evaluation frameworks and can be in tension. Finally, incorporating gamification elements, milestone celebrations, and regular progress updates may help sustain participant engagement across multiple study phases, while developing multilingual materials and hybrid delivery models would enhance true global inclusivity beyond simply enabling international access.</p></sec></sec></body><back><ack><p>The authors gratefully acknowledge the children and parents who participated in The Kid&#x2019;s Trial for their time and engagement. We also thank colleagues across our wider university community, the Toto Centre Initiative, and our broader networks for promoting the study within their communities.</p><p>AI (ChatGPT 5.0) was used in the following 2 ways to help prepare this manuscript: (1) language editing, and (2) drafting R code snippets for the statistical analysis of the Randomized Evaluation of Sleeping With a Toy or Comfort Item (REST) trial consistent with our prespecified statistical analysis plan. All methodological and analysis decisions, and interpretations of results, were made by the authors. The authors ran all analysis code, and checked it for accuracy, with revisions made as necessary, and take full responsibility for the content of the published article. The REST R scripts are available as supporting files in that report [<xref ref-type="bibr" rid="ref30">30</xref>].</p><p>Consent to participate and consent to publish the findings and conclusions in this document are those of the authors and not necessarily those of the National Institute for Health and Care Excellence (NICE) or other authors&#x2019; employing organizations.</p><p>The participant information leaflets approved by the research ethics committee advised participants that the overall findings of The Kid&#x2019;s Trial would be submitted for publication. All participants&#x2019; legal guardians acknowledged that they had read and understood the contents 27 of the participant information leaflets when consenting to their children&#x2019;s participation in The Kid&#x2019;s Trial. Individual participants are not identifiable in any reports or publications. The findings and conclusions in this document are those of the authors and not necessarily those of NICE or other authors&#x2019; employing organizations.</p><p>The findings and conclusions in this document are those of the authors and not necessarily those of NICE or other authors&#x2019; employing organizations.</p><p>This work contributes to one of the authors&#x2019; (SL) doctoral projects.</p></ack><notes><sec><title>Funding</title><p>The Health Research Board &#x2013; Trials Methodology Research Network in Ireland (grant ref: HRB-TMRN-2021&#x2010;001) and the College of Medicine, Nursing and Health Sciences, University of Galway, Ireland, funded this study and SL&#x2019;s PhD studentship. DD is the grant holder. The funders had no role in designing this study, nor in its execution, analyses, data interpretation, or the decision to submit the results.</p></sec><sec><title>Data Availability</title><p>The datasets resulting from The Kid&#x2019;s Trial are not available to the public.</p></sec></notes><fn-group><fn fn-type="con"><p>Conceptualization: DD, LF, SL</p><p>Methodology: DD, LF, SL</p><p>Validation: DD, LF, NT, SL</p><p>Formal analysis: SL</p><p>Investigation: SL</p><p>Data curation: DD, NT, SL</p><p>Writing &#x2013; original draft: SL</p><p>Writing &#x2013; review &#x0026; editing: DD, LF, NT, SL</p><p>Visualization: SL</p><p>Supervision: DD, LF, NT</p><p>Project administration: DD, LF, NT, SL</p><p>Funding acquisition: DD</p></fn><fn fn-type="conflict"><p>None declared.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">CHS</term><def><p>Children Helping Science</p></def></def-item><def-item><term id="abb2">CONSORT</term><def><p>Consolidated Standards of Reporting Trials</p></def></def-item><def-item><term id="abb3">CRAG</term><def><p>Children&#x2019;s Research Advisory Group</p></def></def-item><def-item><term id="abb4">ECS</term><def><p>European Citizen Science</p></def></def-item><def-item><term id="abb5">ITT</term><def><p>intention-to-treat</p></def></def-item><def-item><term id="abb6">PPI</term><def><p>public and patient involvement</p></def></def-item><def-item><term id="abb7">PRAG</term><def><p>Parents&#x2019; Research Advisory Group</p></def></def-item><def-item><term id="abb8">PROMIS</term><def><p>Patient-Reported Outcomes Measurement Information System</p></def></def-item><def-item><term id="abb9">RCT</term><def><p>randomized controlled trial</p></def></def-item><def-item><term id="abb10">REST</term><def><p>Randomized Evaluation of Sleeping With a Toy or Comfort Item</p></def></def-item><def-item><term id="abb11">SAP</term><def><p>statistical analysis plan</p></def></def-item><def-item><term id="abb12">SQS</term><def><p>sleep quality scale</p></def></def-item><def-item><term id="abb13">SRI</term><def><p>sleep-related impairment</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><label>1</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sibbald</surname><given-names>B</given-names> </name><name name-style="western"><surname>Roland</surname><given-names>M</given-names> </name></person-group><article-title>Understanding controlled trials. Why are randomised controlled trials important?</article-title><source>BMJ</source><year>1998</year><month>01</month><day>17</day><volume>316</volume><issue>7126</issue><fpage>201</fpage><pub-id pub-id-type="doi">10.1136/bmj.316.7126.201</pub-id><pub-id pub-id-type="medline">9468688</pub-id></nlm-citation></ref><ref id="ref2"><label>2</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fogel</surname><given-names>DB</given-names> </name></person-group><article-title>Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review</article-title><source>Contemp Clin Trials Commun</source><year>2018</year><month>09</month><volume>11</volume><fpage>156</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/j.conctc.2018.08.001</pub-id><pub-id pub-id-type="medline">30112460</pub-id></nlm-citation></ref><ref id="ref3"><label>3</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pirosca</surname><given-names>S</given-names> </name><name name-style="western"><surname>Shiely</surname><given-names>F</given-names> </name><name name-style="western"><surname>Clarke</surname><given-names>M</given-names> </name><name name-style="western"><surname>Treweek</surname><given-names>S</given-names> </name></person-group><article-title>Tolerating bad health research: the continuing scandal</article-title><source>Trials</source><year>2022</year><month>06</month><day>2</day><volume>23</volume><issue>1</issue><fpage>458</fpage><pub-id pub-id-type="doi">10.1186/s13063-022-06415-5</pub-id><pub-id pub-id-type="medline">35655288</pub-id></nlm-citation></ref><ref id="ref4"><label>4</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Natale</surname><given-names>P</given-names> </name><name name-style="western"><surname>Saglimbene</surname><given-names>V</given-names> </name><name name-style="western"><surname>Ruospo</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Transparency, trust and minimizing burden to increase recruitment and retention in trials: a systematic review</article-title><source>J Clin Epidemiol</source><year>2021</year><month>06</month><volume>134</volume><fpage>35</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2021.01.014</pub-id><pub-id pub-id-type="medline">33515656</pub-id></nlm-citation></ref><ref id="ref5"><label>5</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yadav</surname><given-names>S</given-names> </name><name name-style="western"><surname>Todd</surname><given-names>A</given-names> </name><name name-style="western"><surname>Patel</surname><given-names>K</given-names> </name><etal/></person-group><article-title>Public knowledge and information sources for clinical trials among adults in the USA: evidence from a Health Information National Trends Survey in 2020</article-title><source>Clin Med (Lond)</source><year>2022</year><month>09</month><volume>22</volume><issue>5</issue><fpage>416</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.7861/clinmed.2022-0107</pub-id><pub-id pub-id-type="medline">36507814</pub-id></nlm-citation></ref><ref id="ref6"><label>6</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Langford</surname><given-names>A</given-names> </name><name name-style="western"><surname>Studts</surname><given-names>JL</given-names> </name><name name-style="western"><surname>Byrne</surname><given-names>MM</given-names> </name></person-group><article-title>Improving knowledge and decision readiness to participate in cancer clinical trials: effects of a plain language decision aid for minority cancer survivors</article-title><source>Patient Educ Couns</source><year>2021</year><month>02</month><volume>104</volume><issue>2</issue><fpage>422</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1016/j.pec.2020.07.005</pub-id><pub-id pub-id-type="medline">32660742</pub-id></nlm-citation></ref><ref id="ref7"><label>7</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mackenzie</surname><given-names>IS</given-names> </name><name name-style="western"><surname>Wei</surname><given-names>L</given-names> </name><name name-style="western"><surname>Rutherford</surname><given-names>D</given-names> </name><etal/></person-group><article-title>Promoting public awareness of randomised clinical trials using the media: the &#x201C;Get Randomised&#x201D; campaign</article-title><source>Br J Clin Pharmacol</source><year>2010</year><month>02</month><volume>69</volume><issue>2</issue><fpage>128</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2125.2009.03561.x</pub-id><pub-id pub-id-type="medline">20233175</pub-id></nlm-citation></ref><ref id="ref8"><label>8</label><nlm-citation citation-type="web"><article-title>Increasing clinical trial awareness</article-title><source>Clinical Trials For All</source><year>2025</year><access-date>2026-08-09</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.clinicaltrialsforall.org/">https://www.clinicaltrialsforall.org/</ext-link></comment></nlm-citation></ref><ref id="ref9"><label>9</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Finucane</surname><given-names>E</given-names> </name><name name-style="western"><surname>O&#x2019;Brien</surname><given-names>A</given-names> </name><name name-style="western"><surname>Treweek</surname><given-names>S</given-names> </name><etal/></person-group><article-title>The people&#x2019;s trial: supporting the public&#x2019;s understanding of randomised trials</article-title><source>Trials</source><year>2022</year><month>03</month><day>9</day><volume>23</volume><issue>1</issue><fpage>205</fpage><pub-id pub-id-type="doi">10.1186/s13063-021-05984-1</pub-id><pub-id pub-id-type="medline">35264220</pub-id></nlm-citation></ref><ref id="ref10"><label>10</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mah</surname><given-names>VK</given-names> </name><name name-style="western"><surname>Ford-Jones</surname><given-names>EL</given-names> </name></person-group><article-title>Spotlight on middle childhood: rejuvenating the &#x201C;forgotten years&#x201D;</article-title><source>Paediatr Child Health</source><year>2012</year><month>02</month><volume>17</volume><issue>2</issue><fpage>81</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1093/pch/17.2.81</pub-id><pub-id pub-id-type="medline">23372398</pub-id></nlm-citation></ref><ref id="ref11"><label>11</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shapiro</surname><given-names>T</given-names> </name><name name-style="western"><surname>Perry</surname><given-names>R</given-names> </name></person-group><article-title>Latency revisited. The age 7 plus or minus 1</article-title><source>Psychoanal Study Child</source><year>1976</year><volume>31</volume><fpage>79</fpage><lpage>105</lpage><pub-id pub-id-type="medline">981455</pub-id></nlm-citation></ref><ref id="ref12"><label>12</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nsangi</surname><given-names>A</given-names> </name><name name-style="western"><surname>Semakula</surname><given-names>D</given-names> </name><name name-style="western"><surname>Oxman</surname><given-names>AD</given-names> </name><etal/></person-group><article-title>Effects of the informed health choices primary school intervention on the ability of children in Uganda to assess the reliability of claims about treatment effects, 1-year follow-up: a cluster-randomised trial</article-title><source>Trials</source><year>2020</year><month>01</month><day>6</day><volume>21</volume><issue>1</issue><fpage>27</fpage><pub-id pub-id-type="doi">10.1186/s13063-019-3960-9</pub-id><pub-id pub-id-type="medline">31907013</pub-id></nlm-citation></ref><ref id="ref13"><label>13</label><nlm-citation citation-type="web"><article-title>Health literacy in the context of health, well-being and learning outcomes: the case of children and adolescents in schools</article-title><source>World Health Organization</source><year>2021</year><access-date>2026-08-08</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://iris.who.int/handle/10665/344901">https://iris.who.int/handle/10665/344901</ext-link></comment></nlm-citation></ref><ref id="ref14"><label>14</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borges do Nascimento</surname><given-names>IJ</given-names> </name><name name-style="western"><surname>Pizarro</surname><given-names>AB</given-names> </name><name name-style="western"><surname>Almeida</surname><given-names>JM</given-names> </name><etal/></person-group><article-title>Infodemics and health misinformation: a systematic review of reviews</article-title><source>Bull World Health Organ</source><year>2022</year><month>09</month><day>1</day><volume>100</volume><issue>9</issue><fpage>544</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.2471/BLT.21.287654</pub-id><pub-id pub-id-type="medline">36062247</pub-id></nlm-citation></ref><ref id="ref15"><label>15</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanley</surname><given-names>DF</given-names>  <suffix>Jr</suffix></name><name name-style="western"><surname>Bernard</surname><given-names>GR</given-names> </name><name name-style="western"><surname>Wilkins</surname><given-names>CH</given-names> </name><etal/></person-group><article-title>Decentralized clinical trials in the trial innovation network: value, strategies, and lessons learned</article-title><source>J Clin Transl Sci</source><year>2023</year><volume>7</volume><issue>1</issue><fpage>e170</fpage><pub-id pub-id-type="doi">10.1017/cts.2023.597</pub-id><pub-id pub-id-type="medline">37654775</pub-id></nlm-citation></ref><ref id="ref16"><label>16</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Price</surname><given-names>J</given-names> </name><name name-style="western"><surname>Goodson</surname><given-names>N</given-names> </name><name name-style="western"><surname>Warren</surname><given-names>EJ</given-names> </name><name name-style="western"><surname>Wicks</surname><given-names>P</given-names> </name><name name-style="western"><surname>Reites</surname><given-names>J</given-names> </name></person-group><article-title>Resilient design: decentralized trials recovered faster from the impact of COVID-19 than traditional site-based designs</article-title><source>Expert Rev Med Devices</source><year>2021</year><month>12</month><volume>18</volume><issue>sup1</issue><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1080/17434440.2021.2014818</pub-id><pub-id pub-id-type="medline">34894989</pub-id></nlm-citation></ref><ref id="ref17"><label>17</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goodson</surname><given-names>N</given-names> </name><name name-style="western"><surname>Wicks</surname><given-names>P</given-names> </name><name name-style="western"><surname>Morgan</surname><given-names>J</given-names> </name><name name-style="western"><surname>Hashem</surname><given-names>L</given-names> </name><name name-style="western"><surname>Callinan</surname><given-names>S</given-names> </name><name name-style="western"><surname>Reites</surname><given-names>J</given-names> </name></person-group><article-title>Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusion</article-title><source>NPJ Digit Med</source><year>2022</year><month>05</month><day>5</day><volume>5</volume><issue>1</issue><fpage>58</fpage><pub-id pub-id-type="doi">10.1038/s41746-022-00603-y</pub-id><pub-id pub-id-type="medline">35513479</pub-id></nlm-citation></ref><ref id="ref18"><label>18</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jean-Louis</surname><given-names>G</given-names> </name><name name-style="western"><surname>Seixas</surname><given-names>AA</given-names> </name></person-group><article-title>The value of decentralized clinical trials: inclusion, accessibility, and innovation</article-title><source>Science</source><year>2024</year><month>08</month><day>23</day><volume>385</volume><issue>6711</issue><fpage>eadq4994</fpage><pub-id pub-id-type="doi">10.1126/science.adq4994</pub-id><pub-id pub-id-type="medline">39172847</pub-id></nlm-citation></ref><ref id="ref19"><label>19</label><nlm-citation citation-type="web"><person-group person-group-type="author"><name name-style="western"><surname>Lepage</surname><given-names>S</given-names> </name><name name-style="western"><surname>Lepage</surname><given-names>L</given-names> </name><name name-style="western"><surname>Devane</surname><given-names>D</given-names> </name></person-group><article-title>Co-creating with the scientists of tomorrow: shaping trials and the future</article-title><source>The Kid&#x2019;s Trial</source><year>2025</year><access-date>2026-08-09</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.thekidstrial.ie">https://www.thekidstrial.ie</ext-link></comment></nlm-citation></ref><ref id="ref20"><label>20</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lepage</surname><given-names>S</given-names> </name><name name-style="western"><surname>Whelan</surname><given-names>B</given-names> </name><name name-style="western"><surname>Flight</surname><given-names>L</given-names> </name><name name-style="western"><surname>Totton</surname><given-names>N</given-names> </name><name name-style="western"><surname>Devane</surname><given-names>D</given-names> </name></person-group><article-title>Lessons learned from building the kid&#x2019;s trial with an online children&#x2019;s and parents&#x2019; research advisory group: a descriptive, qualitative study</article-title><source>Res Involv Engagem</source><year>2025</year><month>07</month><day>1</day><volume>11</volume><issue>1</issue><fpage>72</fpage><pub-id pub-id-type="doi">10.1186/s40900-025-00749-5</pub-id><pub-id pub-id-type="medline">40598426</pub-id></nlm-citation></ref><ref id="ref21"><label>21</label><nlm-citation citation-type="web"><article-title>AI-powered insights,backed by real experts</article-title><source>QuestionPro</source><year>2025</year><access-date>2026-08-09</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.questionpro.com/us/">https://www.questionpro.com/us/</ext-link></comment></nlm-citation></ref><ref id="ref22"><label>22</label><nlm-citation citation-type="web"><article-title>Powtoon homepage</article-title><source>Powtoon Ltd</source><year>2025</year><access-date>2026-08-09</access-date><comment><ext-link ext-link-type="uri" xlink:href="http://www.powtoon.com">www.powtoon.com</ext-link></comment></nlm-citation></ref><ref id="ref23"><label>23</label><nlm-citation citation-type="web"><person-group person-group-type="author"><name name-style="western"><surname>Lepage</surname><given-names>S</given-names> </name></person-group><article-title>The kid&#x2019;s trial</article-title><source>YouTube</source><year>2025</year><access-date>2026-08-09</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.youtube.com/@TheKidsTrial">https://www.youtube.com/@TheKidsTrial</ext-link></comment></nlm-citation></ref><ref id="ref24"><label>24</label><nlm-citation citation-type="web"><article-title>European citizen science platform</article-title><source>European Citizen Science Association</source><year>2025</year><access-date>2026-08-09</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://citizenscience.eu/">https://citizenscience.eu/</ext-link></comment></nlm-citation></ref><ref id="ref25"><label>25</label><nlm-citation citation-type="web"><article-title>Children helping science homepage</article-title><source>Children Helping Science</source><year>2025</year><access-date>2026-08-09</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://childrenhelpingscience.com/">https://childrenhelpingscience.com/</ext-link></comment></nlm-citation></ref><ref id="ref26"><label>26</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bevans</surname><given-names>KB</given-names> </name><name name-style="western"><surname>Meltzer</surname><given-names>LJ</given-names> </name><name name-style="western"><surname>De La Motte</surname><given-names>A</given-names> </name><name name-style="western"><surname>Kratchman</surname><given-names>A</given-names> </name><name name-style="western"><surname>Vi&#x00E9;l</surname><given-names>D</given-names> </name><name name-style="western"><surname>Forrest</surname><given-names>CB</given-names> </name></person-group><article-title>Qualitative development and content validation of the PROMIS pediatric sleep health items</article-title><source>Behav Sleep Med</source><year>2019</year><volume>17</volume><issue>5</issue><fpage>657</fpage><lpage>671</lpage><pub-id pub-id-type="doi">10.1080/15402002.2018.1461102</pub-id><pub-id pub-id-type="medline">29693445</pub-id></nlm-citation></ref><ref id="ref27"><label>27</label><nlm-citation citation-type="web"><article-title>PROMIS sleep scoring manual</article-title><source>Health Measures</source><year>2022</year><access-date>2026-08-09</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://healthmeasures.net/select-measures/measure-library/">https://healthmeasures.net/select-measures/measure-library/</ext-link></comment></nlm-citation></ref><ref id="ref28"><label>28</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carle</surname><given-names>AC</given-names> </name><name name-style="western"><surname>Bevans</surname><given-names>KB</given-names> </name><name name-style="western"><surname>Tucker</surname><given-names>CA</given-names> </name><name name-style="western"><surname>Forrest</surname><given-names>CB</given-names> </name></person-group><article-title>Using nationally representative percentiles to interpret PROMIS pediatric measures</article-title><source>Qual Life Res</source><year>2021</year><month>04</month><volume>30</volume><issue>4</issue><fpage>997</fpage><lpage>1004</lpage><pub-id pub-id-type="doi">10.1007/s11136-020-02700-5</pub-id><pub-id pub-id-type="medline">33201388</pub-id></nlm-citation></ref><ref id="ref29"><label>29</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Snyder</surname><given-names>E</given-names> </name><name name-style="western"><surname>Cai</surname><given-names>B</given-names> </name><name name-style="western"><surname>DeMuro</surname><given-names>C</given-names> </name><name name-style="western"><surname>Morrison</surname><given-names>MF</given-names> </name><name name-style="western"><surname>Ball</surname><given-names>W</given-names> </name></person-group><article-title>A new single-item sleep quality scale: results of psychometric evaluation in patients with chronic primary insomnia and depression</article-title><source>J Clin Sleep Med</source><year>2018</year><month>11</month><day>15</day><volume>14</volume><issue>11</issue><fpage>1849</fpage><lpage>1857</lpage><pub-id pub-id-type="doi">10.5664/jcsm.7478</pub-id><pub-id pub-id-type="medline">30373688</pub-id></nlm-citation></ref><ref id="ref30"><label>30</label><nlm-citation citation-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Lepage</surname><given-names>S</given-names> </name><name name-style="western"><surname>Flight</surname><given-names>L</given-names> </name><name name-style="western"><surname>Totton</surname><given-names>N</given-names> </name><name name-style="western"><surname>Devane</surname><given-names>D</given-names> </name></person-group><article-title>The REST (randomised evaluation of sleeping with a toy or comfort item) trial: an online, randomised trial of comfort item use on sleep quality in children</article-title><source>medRxiv</source><comment>Preprint posted online on  Feb 6, 2026</comment><pub-id pub-id-type="doi">10.64898/2026.02.05.26345698</pub-id></nlm-citation></ref><ref id="ref31"><label>31</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lepage</surname><given-names>S</given-names> </name><name name-style="western"><surname>Flight</surname><given-names>L</given-names> </name><name name-style="western"><surname>Totton</surname><given-names>N</given-names> </name><name name-style="western"><surname>Devane</surname><given-names>D</given-names> </name></person-group><article-title>The REST (randomised evaluation of sleeping with a toy or comfort item) trial: a protocol for an online, randomised trial of comfort item use on sleep quality in children</article-title><source>Contemp Clin Trials Commun</source><year>2025</year><month>12</month><volume>48</volume><fpage>101580</fpage><pub-id pub-id-type="doi">10.1016/j.conctc.2025.101580</pub-id><pub-id pub-id-type="medline">41399630</pub-id></nlm-citation></ref><ref id="ref32"><label>32</label><nlm-citation citation-type="web"><person-group person-group-type="author"><name name-style="western"><surname>Lepage</surname><given-names>S</given-names> </name><name name-style="western"><surname>Flight</surname><given-names>L</given-names> </name><name name-style="western"><surname>Totton</surname><given-names>N</given-names> </name><name name-style="western"><surname>Devane</surname><given-names>D</given-names> </name></person-group><article-title>The REST (randomised evaluation of sleeping with a toy or comfort item) trial OSF repository</article-title><source>Open Science Framework</source><year>2025</year><access-date>2026-08-09</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://osf.io/wu7q3/overview">https://osf.io/wu7q3/overview</ext-link></comment></nlm-citation></ref><ref id="ref33"><label>33</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hopewell</surname><given-names>S</given-names> </name><name name-style="western"><surname>Chan</surname><given-names>AW</given-names> </name><name name-style="western"><surname>Collins</surname><given-names>GS</given-names> </name><etal/></person-group><article-title>CONSORT 2025 statement: updated guideline for reporting randomised trials</article-title><source>BMJ</source><year>2025</year><month>04</month><day>14</day><volume>389</volume><fpage>e081123</fpage><pub-id pub-id-type="doi">10.1136/bmj-2024-081123</pub-id><pub-id pub-id-type="medline">40228833</pub-id></nlm-citation></ref><ref id="ref34"><label>34</label><nlm-citation citation-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Kolb</surname><given-names>D</given-names> </name></person-group><source>Experiential Learning: Experience as the Source of Learning and Development</source><year>1984</year><publisher-name>Prentice Hall</publisher-name><pub-id pub-id-type="other">0132952610</pub-id></nlm-citation></ref><ref id="ref35"><label>35</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Biesty</surname><given-names>L</given-names> </name><name name-style="western"><surname>Galvin</surname><given-names>S</given-names> </name><name name-style="western"><surname>Finucane</surname><given-names>E</given-names> </name><name name-style="western"><surname>Healy</surname><given-names>P</given-names> </name><name name-style="western"><surname>Devane</surname><given-names>D</given-names> </name><name name-style="western"><surname>Conway</surname><given-names>T</given-names> </name></person-group><article-title>Can learning about trials be child&#x2019;s play? A qualitative exploration of the &#x201C;Schools Teaching Awareness of Randomised Trials&#x201D; (START) initiative</article-title><source>Trials</source><year>2020</year><month>02</month><day>19</day><volume>21</volume><issue>1</issue><fpage>208</fpage><pub-id pub-id-type="doi">10.1186/s13063-020-4130-9</pub-id><pub-id pub-id-type="medline">32075675</pub-id></nlm-citation></ref><ref id="ref36"><label>36</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blackawton</surname><given-names>PS</given-names> </name><name name-style="western"><surname>Airzee</surname><given-names>S</given-names> </name><name name-style="western"><surname>Allen</surname><given-names>A</given-names> </name><etal/></person-group><article-title>Blackawton bees</article-title><source>Biol Lett</source><year>2011</year><month>04</month><day>23</day><volume>7</volume><issue>2</issue><fpage>168</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1098/rsbl.2010.1056</pub-id><pub-id pub-id-type="medline">21177694</pub-id></nlm-citation></ref><ref id="ref37"><label>37</label><nlm-citation citation-type="web"><article-title>Union measuring digital development: facts and figures 2024</article-title><source>International Telecommunication Union</source><year>2024</year><access-date>2026-08-09</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.itu.int/en/ITU-D/Statistics/pages/facts/default.aspx">https://www.itu.int/en/ITU-D/Statistics/pages/facts/default.aspx</ext-link></comment></nlm-citation></ref></ref-list><app-group><supplementary-material id="app1"><label>Multimedia Appendix 1</label><p>Pre-Trial Quiz.</p><media xlink:href="jmir_v28i1e89240_app1.docx" xlink:title="DOCX File, 553 KB"/></supplementary-material><supplementary-material id="app2"><label>Multimedia Appendix 2</label><p>Sending in your question! survey.</p><media xlink:href="jmir_v28i1e89240_app2.docx" xlink:title="DOCX File, 547 KB"/></supplementary-material><supplementary-material id="app3"><label>Multimedia Appendix 3</label><p>Sorting the questions! survey.</p><media xlink:href="jmir_v28i1e89240_app3.docx" xlink:title="DOCX File, 553 KB"/></supplementary-material><supplementary-material id="app4"><label>Multimedia Appendix 4</label><p>Choosing the question! survey.</p><media xlink:href="jmir_v28i1e89240_app4.docx" xlink:title="DOCX File, 552 KB"/></supplementary-material><supplementary-material id="app5"><label>Multimedia Appendix 5</label><p>Planning the trial! survey.</p><media xlink:href="jmir_v28i1e89240_app5.docx" xlink:title="DOCX File, 554 KB"/></supplementary-material><supplementary-material id="app6"><label>Multimedia Appendix 6</label><p>Running the trial! survey.</p><media xlink:href="jmir_v28i1e89240_app6.docx" xlink:title="DOCX File, 1681 KB"/></supplementary-material><supplementary-material id="app7"><label>Multimedia Appendix 7</label><p>Sharing the results! survey.</p><media xlink:href="jmir_v28i1e89240_app7.docx" xlink:title="DOCX File, 575 KB"/></supplementary-material><supplementary-material id="app8"><label>Multimedia Appendix 8</label><p>Results of the Planning the trial! survey.</p><media xlink:href="jmir_v28i1e89240_app8.pdf" xlink:title="PDF File, 425 KB"/></supplementary-material><supplementary-material id="app9"><label>Multimedia Appendix 9</label><p>Results of the Sharing the results! survey.</p><media xlink:href="jmir_v28i1e89240_app9.pdf" xlink:title="PDF File, 443 KB"/></supplementary-material></app-group></back></article>